Intranasal Oxytocin Dose-Ranging Study Investigates Brain Target Engagement via EEG and Pupil Dilation
Background
Oxytocin is a neuropeptide with established roles in social cognition and behavior, making it a candidate for conditions like schizophrenia and autism spectrum disorder. However, understanding how different doses of intranasal oxytocin translate into specific brain target engagement remains a critical gap. This study aims to define dose-response relationships for oxytocin's effects on neural and physiological markers of social processing, which is essential for optimizing its therapeutic application.
Study Design
This dose-ranging study investigated the effects of 8 doses of intranasal oxytocin or placebo in human subjects. Participants received either oxytocin or placebo. Primary endpoints included the suppression of mu waveform on EEG while observing socially relevant motion, and pupil dilation during the identification of faces showing different emotions. This design aimed to establish target engagement markers across a range of oxytocin concentrations, providing a foundational understanding of its neurophysiological effects.
Why It Matters
Establishing clear dose-response relationships for oxytocin's brain target engagement is crucial for optimizing its therapeutic use. Identifying specific doses that modulate EEG mu waves or pupil dilation could guide more precise clinical protocols for conditions involving social cognitive deficits. This research could inform future trials, helping to determine effective and safe dosing strategies for intranasal oxytocin, potentially improving outcomes in areas like schizophrenia or autism spectrum disorder by ensuring optimal receptor activation and minimizing off-target effects.
oxytocin
intranasal
dose-ranging
eeg
pupil-dilation
social-cognition